Purchase Order 75F40123P00124
Award Date
5/10/23
Potential Completion Date
7/3/28
Potential Value
$187K
Federal Agency
Food and Drug Administration
Awardee
Becton, Dickinson And Company
Ultimate Awardee
Becton, Dickinson & Co
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $431,505.49 firm-fixed-price delivery order contract to Becton, Dickinson and Company (BD) for a flow cytometry system with 5 one-year post-warranty maintenance options. The contract is not set aside. BD is a global medical technology company that provides specialized equipment, reagents, and services for biomedical research and clinical applications. The delivery order likely supports the FDA's work in evaluating and approving medical...
This federal contract was awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Becton, Dickinson And Company (BD), a global medical technology company. The contract is for the maintenance support of a LSRFORTESSA flow cytometry system, a specialized instrument used in biomedical research and clinical applications. The contract is a firm fixed-price purchase order with a potential value of $126,944.40 and a...
The U.S. Food and Drug Administration (FDA) awarded a firm fixed-price delivery order contract to Becton, Dickinson And Company (BD) for the inspection and maintenance of a FACSARIAII cell sorter. The contract has a ceiling value of $79,807.65 and runs through March 31, 2016. BD is a global medical technology company that provides instruments, reagents, and services to support biomedical research and clinical applications, including flow cytometry, cell imaging, and genomics technologies. This...
This is a federal contract award from the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD) for the upgrade of an existing BD Biosciences LSR II flow cytometer. The contract, valued at $166,540.00, is a firm fixed-price purchase order with a completion date of July 22, 2015. BD Biosciences is a division of BD that specializes in flow cytometry, cell imaging, and genomics technologies. BD has an extensive history of providing specialized equipment and consumables to support...
This is a firm fixed-price delivery order for $93,979.84 awarded by the Food and Drug Administration (FDA) to Becton, Dickinson and Company (BD) to provide preventive maintenance and pre-inspection services for a BD Biosciences LSR Fortessa flow cytometer. The contract is under the GSA Scientific Equipment and Services schedule and does not have a set-aside designation. BD Biosciences is a division of the larger Becton, Dickinson and Company that specializes in flow cytometry, cell imaging,...
This is a firm fixed-price delivery order awarded by the Uniformed Services University of the Health Sciences, a defense agency, to Becton, Dickinson And Company (BD), a global medical technology manufacturer. The $134,875.20 contract is for a BD LSR II flow cytometer, a specialized instrument used for biomedical research and clinical applications. BD Biosciences, a division of BD, has extensive experience providing flow cytometry equipment, reagents, and technical support to federal agencies...
This federal contract award is for a Preventive Maintenance Agreement for a BD Flow Cytometer. The contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to the prime contractor Becton, Dickinson and Company (BD), a global medical technology company. The contract is a firm fixed-price Delivery Order with a potential value of $147,871.80 and a completion date of November 26, 2023. The contract was not set aside for any particular business type. BD...
This federal contract award is to Becton, Dickinson and Company (BD) for the provision of a BD LSRFortessa, a specialized flow cytometer. The contract, awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases, has a firm fixed price of $679,200.22 and a completion date of September 21, 2018. The contract is not set aside for any specific business category. BD Biosciences, a division of BD focused on...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to Becton, Dickinson And Company (BD) for maintenance services for one (1) government-owned BD LSRFortessa special order research product (SORP) analytical cytometer. The potential value of the contract is $161,460.00 and the completion date is July 31, 2027. The contract is not set aside and was awarded on August 1, 2022. BD is a global medical technology...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Becton, Dickinson And Company (BD) for the purchase of a BD LSRFortessa instrument. The $278,608.81 firm-fixed-price purchase order was placed on August 28, 2018 and has a completion date of September 21, 2018. The contract did not utilize a set-aside designation. BD is a global medical technology company that develops,...